<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) is the second most common subtype of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) in the Western world </plain></SENT>
<SENT sid="1" pm="."><plain>FL constitutes the most frequent indolent <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, well characterized by its clinical presentation related to nodal involvement and its morphologic and biologic features </plain></SENT>
<SENT sid="2" pm="."><plain>It is often managed as an incurable disease </plain></SENT>
<SENT sid="3" pm="."><plain>However, several active therapeutic approaches from the "wait and watch" strategy to the allogeneic transplantation are available for management of patients with FL and clearly have changed the natural history of this disease, achieving a long-term disease-free survival </plain></SENT>
<SENT sid="4" pm="."><plain>Therapeutic decision is mostly conditioned by patient's characteristics, stage, histological grade, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden, and risk-predicting factors </plain></SENT>
<SENT sid="5" pm="."><plain>This article try to summarizes the diagnosis and treatment of this <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of patients </plain></SENT>
</text></document>